MONTREAL,
June 8,
2022 /CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH)
(OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"),
a Canadian pharmaceutical company, announced today that it will
report its financial results and highlights for the second quarter
ended April 30, 2022 on Tuesday June 14, 2022 after market close. The
Company will host a conference call to discuss those results and
highlights on Wednesday June 15, 2022
at 8.30am (ET).
Conference ID:
|
49147207
|
|
|
Date:
|
Wednesday, June 15,
2022
|
|
|
Time:
|
8:30am ET
|
|
|
Dial-in numbers:
|
1-888-664-6392 or
416-764-8659
|
|
|
Audio replay numbers:
|
1-888-390-0541 or
416-764-8677
|
|
|
Replay code:
|
147207#
|
A live audio webcast of the conference call will
be available via:
https://produceredition.webcasts.com/starthere.jsp?ei=1553257&tp_key=74c181ca17
About Valeo Pharma
Valeo Pharma is a Canadian pharmaceutical company
dedicated to the commercialization of innovative prescription
products in Canada with a focus on
Respiratory diseases, Neurodegenerative Diseases, Oncology and
Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the
required capabilities and the full infrastructure to register and
properly manage its growing product portfolio through all stages of
commercialization. For more information, please visit
www.valeopharma.com and follow us on LinkedIn and Twitter.
Forward Looking
Statements
This press release contains forward-looking
statements about Valeo's objectives, strategies and businesses that
involve risks and uncertainties. These statements are
"forward-looking" because they are based on our current
expectations about the markets we operate in and on various
estimates and assumptions. Actual events or results may differ
materially from those anticipated in these forward-looking
statements if known or unknown risks affect our business, or if our
estimates or assumptions turn out to be inaccurate.
SOURCE Valeo Pharma Inc.